Wells Fargo & Company downgraded Amrize from a strong-buy rating to hold. The stock opened trading near its 52-week low of $40.92.
Amrize recently reported quarterly earnings of $0.88 per share. This figure missed the consensus estimate of $0.92 per share.
Truist and Bank of America also reduced their price targets for the company earlier this month. The consensus rating for Amrize among investment analysts is currently hold. The average price target for the stock stands at $55.50.